Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 2
1938 1
1948 1
1950 2
1952 1
1953 1
1954 1
1964 3
1965 3
1967 5
1968 2
1969 3
1970 5
1971 4
1972 3
1973 6
1974 8
1975 6
1976 6
1977 3
1978 11
1979 8
1980 6
1981 9
1982 10
1983 10
1984 12
1985 20
1986 13
1987 11
1988 14
1989 12
1990 9
1991 23
1992 18
1993 20
1994 38
1995 42
1996 37
1997 30
1998 31
1999 37
2000 53
2001 50
2002 45
2003 63
2004 59
2005 89
2006 125
2007 133
2008 173
2009 168
2010 174
2011 207
2012 252
2013 238
2014 282
2015 277
2016 306
2017 352
2018 340
2019 380
2020 497
2021 602
2022 556
2023 550
2024 195

Text availability

Article attribute

Article type

Publication date

Search Results

5,793 results

Results by year

Filters applied: . Clear all
Page 1
Keratosis pilaris: an update and approach to management.
Kodali N, Patel VM, Schwartz RA. Kodali N, et al. Among authors: patel vm. Ital J Dermatol Venerol. 2023 Jun;158(3):217-223. doi: 10.23736/S2784-8671.23.07594-1. Epub 2023 May 11. Ital J Dermatol Venerol. 2023. PMID: 37166753 Free article. Review.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. Among authors: patel v. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Russell MD, Stovin C, Alveyn E, Adeyemi O, Chan CKD, Patel V, Adas MA, Atzeni F, Ng KKH, Rutherford AI, Norton S, Cope AP, Galloway JB. Russell MD, et al. Among authors: patel v. Ann Rheum Dis. 2023 Aug;82(8):1059-1067. doi: 10.1136/ard-2023-224049. Epub 2023 May 29. Ann Rheum Dis. 2023. PMID: 37247942 Free PMC article.
Adverse childhood experiences and lifelong health.
Bhutta ZA, Bhavnani S, Betancourt TS, Tomlinson M, Patel V. Bhutta ZA, et al. Among authors: patel v. Nat Med. 2023 Jul;29(7):1639-1648. doi: 10.1038/s41591-023-02426-0. Epub 2023 Jul 18. Nat Med. 2023. PMID: 37464047 Review.
Protein supplementation: the double-edged sword.
Patel V, Aggarwal K, Dhawan A, Singh B, Shah P, Sawhney A, Jain R. Patel V, et al. Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):118-126. doi: 10.1080/08998280.2023.2280417. eCollection 2024. Proc (Bayl Univ Med Cent). 2023. PMID: 38174000 Free PMC article. Review.
Cydnidae Pigmentation.
Patel V, Sathyan A. Patel V, et al. J Cutan Med Surg. 2024 Mar 6:12034754241235967. doi: 10.1177/12034754241235967. Online ahead of print. J Cutan Med Surg. 2024. PMID: 38445616 No abstract available.
Traction Alopecia.
Patel V, Fatma ZH. Patel V, et al. J Cutan Med Surg. 2024 Feb 5:12034754241229331. doi: 10.1177/12034754241229331. Online ahead of print. J Cutan Med Surg. 2024. PMID: 38314741 No abstract available.
Circinate Balanitis.
Choudhary R, Patel V. Choudhary R, et al. Among authors: patel v. J Cutan Med Surg. 2024 Jan-Feb;28(1):101. doi: 10.1177/12034754231224367. Epub 2024 Jan 9. J Cutan Med Surg. 2024. PMID: 38196187 No abstract available.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Ghilardi G, Fraietta JA, Gerson JN, Van Deerlin VM, Morrissette JJD, Caponetti GC, Paruzzo L, Harris JC, Chong EA, Susanibar Adaniya SP, Svoboda J, Nasta SD, Ugwuanyi OH, Landsburg DJ, Fardella E, Waxman AJ, Chong ER, Patel V, Pajarillo R, Kulikovskaya I, Lieberman DB, Cohen AD, Levine BL, Stadtmauer EA, Frey NV, Vogl DT, Hexner EO, Barta SK, Porter DL, Garfall AL, Schuster SJ, June CH, Ruella M. Ghilardi G, et al. Among authors: patel v. Nat Med. 2024 Apr;30(4):984-989. doi: 10.1038/s41591-024-02826-w. Epub 2024 Jan 24. Nat Med. 2024. PMID: 38266761
5,793 results